Edurado Romano1, Pedro Torres-Saavedra2, Robert B Voas1, John H Lacey1. 1. Pacific Institute for Research and Evaluation, Calverton, Maryland. 2. Department of Mathematical Sciences, University of Puerto Rico at Mayagüez, Mayagüez, Puerto Rico.
Abstract
OBJECTIVE: The purpose of this study was to determine (a) whether among sober (blood alcohol concentration [BAC] = .00%) drivers, being drug positive increases the drivers' risk of being killed in a fatal crash; (b) whether among drinking (BAC > .00%) drivers, being drug positive increases the drivers' risk of being killed in a fatal crash; and (c) whether alcohol and other drugs interact in increasing crash risk. METHOD: We compared BACs for the 2006, 2007, and 2008 crash cases drawn from the U.S. Fatality Analysis Reporting System (FARS) with control drug and blood alcohol data from participants in the 2007 U.S. National Roadside Survey. Only FARS drivers from states with drug information on 80% or more of the drivers who also participated in the 2007 National Roadside Survey were selected. RESULTS: For both sober and drinking drivers, being positive for a drug was found to increase the risk of being fatally injured. When the drug-positive variable was separated into marijuana and other drugs, only the latter was found to contribute significantly to crash risk. In all cases, the contribution of drugs other than alcohol to crash risk was significantly lower than that produced by alcohol. CONCLUSIONS: Although overall, drugs contribute to crash risk regardless of the presence of alcohol, such a contribution is much lower than that by alcohol. The lower contribution of drugs other than alcohol to crash risk relative to that of alcohol suggests caution in focusing too much on drugged driving, potentially diverting scarce resources from curbing drunk driving.
RCT Entities:
OBJECTIVE: The purpose of this study was to determine (a) whether among sober (blood alcohol concentration [BAC] = .00%) drivers, being drug positive increases the drivers' risk of being killed in a fatal crash; (b) whether among drinking (BAC > .00%) drivers, being drug positive increases the drivers' risk of being killed in a fatal crash; and (c) whether alcohol and other drugs interact in increasing crash risk. METHOD: We compared BACs for the 2006, 2007, and 2008 crash cases drawn from the U.S. Fatality Analysis Reporting System (FARS) with control drug and blood alcohol data from participants in the 2007 U.S. National Roadside Survey. Only FARS drivers from states with drug information on 80% or more of the drivers who also participated in the 2007 National Roadside Survey were selected. RESULTS: For both sober and drinking drivers, being positive for a drug was found to increase the risk of being fatally injured. When the drug-positive variable was separated into marijuana and other drugs, only the latter was found to contribute significantly to crash risk. In all cases, the contribution of drugs other than alcohol to crash risk was significantly lower than that produced by alcohol. CONCLUSIONS: Although overall, drugs contribute to crash risk regardless of the presence of alcohol, such a contribution is much lower than that by alcohol. The lower contribution of drugs other than alcohol to crash risk relative to that of alcohol suggests caution in focusing too much on drugged driving, potentially diverting scarce resources from curbing drunk driving.
Authors: Annick Ménétrey; Marc Augsburger; Bernard Favrat; Marie A Pin; Laura E Rothuizen; Monique Appenzeller; Thierry Buclin; Patrice Mangin; Christian Giroud Journal: J Anal Toxicol Date: 2005 Jul-Aug Impact factor: 3.367
Authors: Mark J Rapoport; Krista L Lanctôt; David L Streiner; Michel Bédard; Evelyn Vingilis; Brian Murray; Ayal Schaffer; Kenneth I Shulman; Nathan Herrmann Journal: J Clin Psychiatry Date: 2009-04-21 Impact factor: 4.384
Authors: June H Kim; Julian Santaella-Tenorio; Christine Mauro; Julia Wrobel; Magdalena Cerdà; Katherine M Keyes; Deborah Hasin; Silvia S Martins; Guohua Li Journal: Am J Public Health Date: 2016-09-15 Impact factor: 9.308
Authors: Athanasia H Papalimperi; Sotirios A Athanaselis; Areti D Mina; Ioannis I Papoutsis; Chara A Spiliopoulou; Stavroula A Papadodima Journal: Exp Ther Med Date: 2019-07-17 Impact factor: 2.447
Authors: Eduardo Romano; Pedro A Torres-Saavedra; Hilda I Calderón Cartagena; Robert B Voas; Anthony Ramírez Journal: J Stud Alcohol Drugs Date: 2018-07 Impact factor: 2.582
Authors: Marlene C Lira; Vishnudas Sarda; Timothy C Heeren; Matthew Miller; Timothy S Naimi Journal: Am J Prev Med Date: 2020-03-16 Impact factor: 5.043